Havas ECS:

The science behind the system

Havas Health & You introduces Havas ECS (Endocannabinoid Science), a strategic communications advisory and education company focused on the importance and value of foundational scientific knowledge of the endocannabinoid system, to better guide and better inform improved decision making on ECS-related topics.

Fueled by deep subject matter expertise, and a network of medical advisors skilled in the application of cannabinoid medicine, Havas ECS helps clients seeking a science-based approach to their communications needs.

Medical Cannabis Logo

Thank you to everyone

who attended and participated in the Science of Cannabis Symposium on November 15th.

Conference presentation
Conference presentation
Conference presentation
Conference presentation

Thank you to all sponsors of this year's event.

American Journal Endocannabinoid Medicine Logo
Connect Medical Legal Experts Logo
Medpage Today Logo
Everyday Health Logo

Therapeutic areas where cannabinoid
therapies are being researched

  • Alzheimer’s disease
  • Anorexia
  • Autism spectrum disorders
  • Autoimmune disease and inflammation
  • Bladder dysfunction
  • Cancer
  • Chronic pain
  • Epilepsy
  • Fragile X syndrome
  • Glaucoma
  • Insomnia
  • Migraine
  • Multiple sclerosis
  • Neonatal hypoxic-ischemic encephalopathy
  • Neuropathy (neuropathic pain)
  • Schizophrenia
  • Spinal cord injury

Havas ECS: Experience

Rob Dhoble headshot

Rob is an experienced communications executive, healthcare strategist, and leader of cross‑functional teams. Rob and his Havas team serve to advance the understanding of cannabinoid health and wellness, with science‑based education and communication programs that frame and elevate the cannabinoid conversation, and increase understanding of cannabinoid treatments and ECS‑related medical conditions.

Rob Dhoble, Managing Director
E: rob.dhoble@havas.com